Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 2.250
-0.060 (-2.60%)
Jun 5, 2026, 4:10 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 837.58 million as of June 5, 2026. Its market cap has increased by 17.94% in one year.
Market Cap
837.58M
Enterprise Value
611.33M
Revenue
10.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.25
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 837.58M, an increase of 118.01%. That is a compound annual growth rate of 17.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 837.58M | -33.39% |
| Dec 31, 2025 | 1.26B | -6.00% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
| Aug 25, 2021 | 384.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 4.52B |
| Mesoblast | 2.66B |
| Neuren Pharmaceuticals | 1.72B |
| PYC Therapeutics | 1.21B |
| Racura Oncology | 505.16M |
| Clinuvel Pharmaceuticals | 460.41M |
| Starpharma Holdings | 317.97M |
| Tetratherix | 299.52M |